Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | SVP, Fin & Princ Acct Officer | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,516 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Tax withholding · Disposed 937 · Balance 34,516 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 20:43 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 937 | $17.89 | $16,762.93 |
DisclosureSEC source: 0001719686-26-000003 · wk-form4_1783370616.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,516 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 15,957 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · derivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,957 Underlying: Common Stock · 15,957 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 806 | $9.61 | $7,745.66 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,453 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 341 | $9.55 | $3,256.55 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,259 Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 21:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 3,345 | $13.49 | $45,124.05 |
DisclosureSEC source: 0000917520-25-000062 · wk-form4_1751922355.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,600 Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 937 | $13.25 | $12,415.25 |
DisclosureSEC source: 0000917520-25-000061 · wk-form4_1751487563.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,945 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 5,514 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000027 · wk-form4_1741897707.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,882 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 309 | $23.95 | $7,400.55 |
DisclosureSEC source: 0000917520-25-000027 · wk-form4_1741897707.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,368 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 134 | $23.95 | $3,209.30 |
DisclosureSEC source: 0000917520-25-000027 · wk-form4_1741897707.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,677 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 166 | $22.61 | $3,753.26 |
DisclosureSEC source: 0000917520-25-000022 · wk-form4_1741725114.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,811 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 111 | $22.61 | $2,509.71 |
DisclosureSEC source: 0000917520-25-000022 · wk-form4_1741725114.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,977 Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,191 | $21.58 | $25,700.83 |
DisclosureSEC source: 0000917520-24-000095 · wk-form4_1724185315.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,088 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $21.575 to $21.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 10,356 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000086 · wk-form4_1719952041.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,279 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 124 | $35.88 | $4,449.12 |
DisclosureSEC source: 0000917520-24-000030 · wk-form4_1710361498.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,923 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 223 | $35.88 | $8,001.24 |
DisclosureSEC source: 0000917520-24-000030 · wk-form4_1710361498.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,047 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000030 · wk-form4_1710361498.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,270 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 130 | $36.22 | $4,708.60 |
DisclosureSEC source: 0000917520-24-000030 · wk-form4_1710361498.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,860 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 166 | $36.73 | $6,097.18 |
DisclosureSEC source: 0000917520-24-000026 · wk-form4_1710277986.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,990 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 110 | $36.73 | $4,040.30 |
DisclosureSEC source: 0000917520-24-000026 · wk-form4_1710277986.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,156 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000006 · wk-form4_1708638439.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,266 F1 · shares: On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,177 | $44.46 | $52,329.42 |
DisclosureSEC source: 0001209191-23-045304 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,458 Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 12,196 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-017116 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,635 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 64 | $52.61 | $3,367.04 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 9 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,439 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 140 | $52.61 | $7,365.40 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 8 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,503 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 121 | $52.87 | $6,397.27 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 7 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,643 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 64 | $52.87 | $3,383.68 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 106 | $52.87 | $5,604.22 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 130 | $52.87 | $6,873.10 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,934 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 113 | $52.87 | $5,974.31 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,064 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,177 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,921 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,089 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,678 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,293 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,062 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| December 08, 2022 Filed Dec 8, 2022 22:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 279 | $56.22 | $15,684.32 |
DisclosureSEC source: 0001209191-22-060378 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,552 Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 20:42 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 437 | $56.78 | $24,810.68 |
DisclosureSEC source: 0001209191-22-044207 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,831 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 232 | $65.11 | $15,105.52 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 8 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,268 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 164 | $65.11 | $10,678.04 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 7 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 62 | $65.11 | $4,036.82 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,664 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 44 | $65.11 | $2,864.84 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,726 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 144 | $65.11 | $9,375.84 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,770 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 240 | $65.11 | $15,626.40 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,914 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 120 | $65.11 | $7,813.20 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,154 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018835 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,274 Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009369 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,844 F3 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 843 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009369 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,446 F2 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009369 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,603 F1 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 700 | $70.88 | $49,616.00 |
DisclosureSEC source: 0001209191-21-064163 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,008 Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 41 | $68.10 | $2,792.10 |
DisclosureSEC source: 0001209191-21-020765 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,708 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.